These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37725983)

  • 1. IκBζ is an essential mediator of immunity to oropharyngeal candidiasis.
    Taylor TC; Coleman BM; Arunkumar SP; Dey I; Dillon JT; Ponde NO; Poholek AC; Schwartz DM; McGeachy MJ; Conti HR; Gaffen SL
    Cell Host Microbe; 2023 Oct; 31(10):1700-1713.e4. PubMed ID: 37725983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.
    Ferreira MC; Whibley N; Mamo AJ; Siebenlist U; Chan YR; Gaffen SL
    Infect Immun; 2014 Mar; 82(3):1030-5. PubMed ID: 24343647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins.
    Simpson-Abelson MR; Childs EE; Ferreira MC; Bishu S; Conti HR; Gaffen SL
    PLoS One; 2015; 10(8):e0136538. PubMed ID: 26317211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis.
    Conti HR; Bruno VM; Childs EE; Daugherty S; Hunter JP; Mengesha BG; Saevig DL; Hendricks MR; Coleman BM; Brane L; Solis N; Cruz JA; Verma AH; Garg AV; Hise AG; Richardson JP; Naglik JR; Filler SG; Kolls JK; Sinha S; Gaffen SL
    Cell Host Microbe; 2016 Nov; 20(5):606-617. PubMed ID: 27923704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis.
    Yang L; Cheng T; Shao J
    Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37533203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.
    Conti HR; Shen F; Nayyar N; Stocum E; Sun JN; Lindemann MJ; Ho AW; Hai JH; Yu JJ; Jung JW; Filler SG; Masso-Welch P; Edgerton M; Gaffen SL
    J Exp Med; 2009 Feb; 206(2):299-311. PubMed ID: 19204111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis.
    Aggor FEY; Break TJ; Trevejo-Nuñez G; Whibley N; Coleman BM; Bailey RD; Kaplan DH; Naglik JR; Shan W; Shetty AC; McCracken C; Durum SK; Biswas PS; Bruno VM; Kolls JK; Lionakis MS; Gaffen SL
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32503875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections.
    Bishu S; Hernández-Santos N; Simpson-Abelson MR; Huppler AR; Conti HR; Ghilardi N; Mamo AJ; Gaffen SL
    Infect Immun; 2014 Mar; 82(3):1173-80. PubMed ID: 24379290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.
    Huppler AR; Conti HR; Hernández-Santos N; Darville T; Biswas PS; Gaffen SL
    J Immunol; 2014 Feb; 192(4):1745-52. PubMed ID: 24442441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.
    Goupil M; Cousineau-Côté V; Aumont F; Sénéchal S; Gaboury L; Hanna Z; Jolicoeur P; de Repentigny L
    BMC Immunol; 2014 Oct; 15():49. PubMed ID: 25344377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
    J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aryl Hydrocarbon Receptor Governs Epithelial Cell Invasion during Oropharyngeal Candidiasis.
    Solis NV; Swidergall M; Bruno VM; Gaffen SL; Filler SG
    mBio; 2017 Mar; 8(2):. PubMed ID: 28325761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
    Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
    Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.
    Whibley N; Tritto E; Traggiai E; Kolbinger F; Moulin P; Brees D; Coleman BM; Mamo AJ; Garg AV; Jaycox JR; Siebenlist U; Kammüller M; Gaffen SL
    J Leukoc Biol; 2016 Jun; 99(6):1153-64. PubMed ID: 26729813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Chelator Deferasirox Reduces
    Puri S; Kumar R; Rojas IG; Salvatori O; Edgerton M
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718249
    [No Abstract]   [Full Text] [Related]  

  • 16. Systematic Genetic Interaction Analysis Identifies a Transcription Factor Circuit Required for Oropharyngeal Candidiasis.
    Solis NV; Wakade RS; Glazier VE; Ollinger TL; Wellington M; Mitchell AP; Filler SG; Krysan DJ
    mBio; 2022 Feb; 13(1):e0344721. PubMed ID: 35012341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida albicans Oropharyngeal Infection Is an Exception to Iron-Based Nutritional Immunity.
    Solis NV; Wakade RS; Filler SG; Krysan DJ
    mBio; 2023 Apr; 14(2):e0009523. PubMed ID: 36912640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.
    Peters BM; Coleman BM; Willems HME; Barker KS; Aggor FEY; Cipolla E; Verma AH; Bishu S; Huppler AH; Bruno VM; Gaffen SL
    J Infect Dis; 2020 Apr; 221(9):1554-1563. PubMed ID: 31805183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.
    Conti HR; Baker O; Freeman AF; Jang WS; Holland SM; Li RA; Edgerton M; Gaffen SL
    Mucosal Immunol; 2011 Jul; 4(4):448-55. PubMed ID: 21346738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coptidis rhizoma extract alleviates oropharyngeal candidiasis by gC1qR-EGFR/ERK/c-fos axis-induced endocytosis of oral epithelial cells.
    Bao M; Bu Q; Pan M; Xu R; Chen Y; Yang Y; Wang C; Wang T
    J Ethnopharmacol; 2024 Sep; 331():118305. PubMed ID: 38729536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.